Bio/Pharma News

Mar 29, 2018
By Pharmaceutical Technology Editors
The companies will co-develop and co-promote a CAR-T cell therapy in the United States.
Mar 29, 2018
By Pharmaceutical Technology Editors
The acquisition strengthens Celgene’s position in the global cellular immunotherapy space.
Mar 28, 2018
By Pharmaceutical Technology Editors
Takeda is considering approaching Shire with a possible offer.
Mar 27, 2018
By Pharmaceutical Technology Editors
In a $13-billion transaction, GSK will purchase Novartis’ share of the Consumer Healthcare Joint Venture.
Mar 26, 2018
By Pharmaceutical Technology Editors
Hitachi will manufacture regenerative medicines developed by Daiichi Sankyo and SanBio Group.
Mar 23, 2018
By Pharmaceutical Technology Editors
The collaboration between the two companies aims to finish all necessary work needed to file for a first-in-human study by early 2019.
Mar 22, 2018
By Pharmaceutical Technology Editors
Helsinn will acquire the global rights to Valchlor/Ledaga (mechlorethamine/chlormethine), a topical skin-cancer drug, from Actelion Pharmaceuticals.
Mar 21, 2018
By Pharmaceutical Technology Editors
AbbVie and the International Myeloma Foundation will partner to study the role of a genetic mutation in outcomes of patients with multiple myeloma.
Mar 19, 2018
By Pharmaceutical Technology Editors
The companies intend to jointly develop and commercialize Lenvima (lenvatinib mesylate) as a monotherapy and an in-combination therapy for treating multiple cancer types.
Mar 19, 2018
By Pharmaceutical Technology Editors
Biogen will acquire an AMPA receptor potentiator for cognitive impairment associated with schizophrenia in a deal worth approximately $590 million.
native1_300x100
lorem ipsum